Expo Hub
Liver Cancer
Journey
Follow Ben on his individual Cancer Pathway
1Global burden of primary liver cancer in 2020 and predictions to 2040, 05, 2022. DOI:https://doi.org/10.1016/j.jhep.2022.08.021.
2Nature Reviews, Llovet et al, 2020. https://doi.org/10.1038/s41572-020-00240-3).
3MASLD = metabolic dysfunction-associated steatotic liver disease; HCC = hepatocellular carcinoma; ELF test = enhanced liver fibrosis; FIB-4 index = fibrosis 4
In the U.S., the ELF Test is indicated as a prognostic marker in conjunction with other laboratory findings and clinical assessments in patients with advanced fibrosis (F3 or F4) due to non-alcoholic steatohepatitis (NASH) to assess the likelihood of progression to cirrhosis and liver-related clinical events. In the U.S., the ELF Test is not for use in the diagnosis of NASH, for the staging of fibrosis, or for assessing progression to hepatocellular carcinoma.
In the U.S., the ELF Test is indicated as a prognostic marker in conjunction with other laboratory findings and clinical assessments in patients with advanced fibrosis (F3 or F4) due to non-alcoholic steatohepatitis (NASH) to assess the likelihood of progression to cirrhosis and liver-related clinical events. In the U.S., the ELF Test is not for use in the diagnosis of NASH, for the staging of fibrosis, or for assessing progression to hepatocellular carcinoma.
4UDFF = ultrasound derived fat fraction; Auto pSWE = automated point shear wave elastography; MASLD = metabolic dysfunction-associated steatotic liver disease; MASH = metabolic dysfunction-associated steatohepatitis, US = ultrasound; PDFF = proton density fat fraction
5MAGNETOM Cima.X is pending 510(k) clearance, and is not yet commercially available in the United States. Its future availability cannot be guaranteed.
6Compressed Sensing GRASP-VIBE for other regions than liver is not for sale in the U.S.
7The information shown herein refers to products of 3rd party manufacturers. The product is still under development and not commercially available. Its future availability cannot be ensured
8The products / features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.